TY - JOUR T1 - Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1186/s40425-019-0559-3 VL - 7 IS - 1 SP - 73 AU - Asim Amin AU - Elizabeth R. Plimack AU - Marc S. Ernstoff AU - Lionel D. Lewis AU - Todd M. Bauer AU - David F. McDermott AU - Michael Carducci AU - Christian Kollmannsberger AU - Brian I. Rini AU - Daniel Y. C. Heng AU - Jennifer Knox AU - Martin H. Voss AU - Jennifer Spratlin AU - Elmer Berghorn AU - Lingfeng Yang AU - Hans J. Hammers Y1 - 2019/12/01 UR - http://jitc.bmj.com/content/7/1/73.abstract N2 - .The original article can be found online at 10.1186/s40425-018-0420-0 ER -